Error: Could not add to watchlist. X
+ Watchlist

Cell Genesys Inc

CEGE:US
Acquired
CEGE:US was acquired by ANIP:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.083
Market Cap (USD)
-
Shares Outstanding (m)
109.651
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Cell Genesys Inc. provides biological therapies for cancer patients. The Company researches and develops cancer vaccines, oncolytic virus therapies, and cancer gene therapies. Cell Genesys serves the healthcare industry in the United States.
Address
24590 Clawiter Road
Hayward, CA 94545
United States
Phone
1-650-266-3000
Website
-